Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News iRhythm Technologies Inc IRTC

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac... see more

Recent & Breaking News (NDAQ:IRTC)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC

Newsfile June 13, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire June 10, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire June 7, 2023

iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments

GlobeNewswire June 6, 2023

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire June 6, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC

PR Newswire June 5, 2023

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile June 5, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire June 5, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC

Newsfile June 3, 2023

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire June 2, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Accesswire June 1, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire June 1, 2023

iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference

GlobeNewswire May 24, 2023

New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias

GlobeNewswire May 22, 2023

iRhythm Technologies Announces First Quarter 2023 Financial Results

GlobeNewswire May 4, 2023

iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023

GlobeNewswire April 20, 2023

iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth

GlobeNewswire April 12, 2023

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors

GlobeNewswire March 6, 2023

Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC

GlobeNewswire March 2, 2023

iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire February 23, 2023
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse